World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
UK
2026

D-Index & Metrics

Best Scientists

D-Index
226
Citations
296149
World Ranking
109
National Ranking
13

Medicine

D-Index
228
Citations
283029
World Ranking
66
National Ranking
8

Research.com Recognitions

  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award
  • 2022 - Research.com Medicine in United Kingdom Leader Award
  • 2008 - Fellow of the Royal Society of Edinburgh
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

John J.V. McMurray is affiliated with the University of Glasgow in the United Kingdom. Their research primarily focuses on Medicine, with a strong emphasis on Cardiology and Cardiovascular Medicine. Other notable subfields of study include Endocrinology, Diabetes and Metabolism, Surgery, Pulmonary and Respiratory Medicine, and Nephrology.

The scientist's main topics of work cover several critical areas, including:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Diabetes Treatment and Management
  • Pancreatic Function and Diabetes
  • Cardiac Pacing and Defibrillation Studies
  • Hormonal Regulation and Hypertension
  • Potassium and Related Disorders

McMurray has contributed numerous papers to leading journals. Recent notable publications include:

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2021, European Heart Journal
  • Dapagliflozin in Patients with Chronic Kidney Disease, 2020, New England Journal of Medicine
  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction, 2022, New England Journal of Medicine
  • Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19, 2020, New England Journal of Medicine
  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2022, European Journal of Heart Failure

Their frequent co-authors include:

  • Scott D. Solomon
  • Pardeep S. Jhund
  • Brian Claggett
  • Muthiah Vaduganathan
  • Akshay S. Desai

John J.V. McMurray has published extensively in several well-regarded scientific journals. The most frequent publication venues are:

  • European Journal of Heart Failure
  • European Heart Journal
  • JACC Heart Failure
  • Journal of the American College of Cardiology
  • Circulation

The scientist has received recognition including being named a Fellow of the Royal Society of Edinburgh in 2008 and elected as a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

    Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

  • 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler

  • 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

    Paulus Kirchhof;Stefano Benussi;Dipak Kotecha;Anders Ahlsson

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

    Theresa A McDonagh;Marco Metra;Marianna Adamo;Roy S Gardner

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio

  • Angiotensin-neprilysin inhibition versus enalapril in heart failure.

    John J. V. McMurray;Milton Packer;Akshay S. Desai;Jianjian Gong

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

    Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray

  • 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler

  • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

    Christopher B Granger;John J V McMurray;Salim Yusuf;Peter Held

  • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

    Salim Yusuf;Marc A Pfeffer;Karl Swedberg;Christopher B Granger

  • Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

    Faiez Zannad;John J. V. McMurray;Henry Krum;Dirk J. van Veldhuisen

  • Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology

    Alec Vahanian;Helmut Baumgartner;Jeroen Bax;Eric Butchart

  • Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

    Marc A. Pfeffer;John J.V. McMurray;Eric J. Velazquez;Jean-Lucien Rouleau

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

    Scott D. Solomon;John J.V. McMurray;Marc A. Pfeffer;Janet Wittes

  • Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

    Marc A Pfeffer;Karl Swedberg;Christopher B Granger;Peter Held

  • Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

    Nagesh S Anavekar;John J V McMurray;Eric J Velazquez;Scott D Solomon

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Marc A. Pfeffer;Brian L. Claggett;Rafael Diaz;Kenneth Dickstein

  • A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

    Marc A Pfeffer;Emmanuel A. Burdmann;Chao Yin Chen;Mark E. Cooper

Frequent Co-Authors

Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Karl Swedberg
Karl Swedberg University of Gothenburg
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Pardeep S. Jhund
Pardeep S. Jhund University of Glasgow
Lars Køber
Lars Køber Copenhagen University Hospital
Michael R. Zile
Michael R. Zile Medical University of South Carolina
Mark C. Petrie
Mark C. Petrie University of Glasgow
Brian Claggett
Brian Claggett Brigham and Women's Hospital
Akshay S. Desai
Akshay S. Desai Brigham and Women's Hospital
Aldo P. Maggioni
Aldo P. Maggioni Heart Care Foundation, ANMCO Research Center, Florence

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a wide range of online healthcare degrees and career paths. If you’re looking for flexible options with strong job prospects, you might consider online medical billing and coding schools that accept fafsa. These programs allow you to begin a vital healthcare career in as little as one year, with financial aid available.

For those interested in direct patient care but concerned about entrance exams, several nursing school that doesn't require teas provide a quicker, less stressful path to a nursing credential.

If rapid advancement is your goal, consider accelerated healthcare programs. These shorten the time needed to earn a bachelor’s or master’s degree in healthcare administration, preparing you faster for leadership roles.

Registered nurses seeking further advancement can explore asn to np bridge programs, which connect an associate’s degree in nursing to a nurse practitioner credential. Whatever your interests, online programs offer flexible entry points for aspiring healthcare professionals.

Best Scientists Citing John J.V. McMurray

Trending Scientists